Emerging indications for permanent pacing.

Area of Science:

• Cardiology
• Electrophysiology
• Medical Device Technology

Background:

• Pacemaker technology is evolving beyond traditional uses.
• Investigating new applications for pacing in complex cardiovascular conditions.
• Exploring pacing as an alternative for patients unresponsive to medical treatments.

Purpose of the Study:

• To review current and emerging indications for cardiac pacing.
• To evaluate the efficacy of pacing in vasovagal syncope, cardiomyopathies, and atrial fibrillation.
• To identify areas for technological advancement in pacing lead systems.

Main Methods:

• Review of current clinical data and ongoing research in cardiac pacing.
• Analysis of patient outcomes for various pacing strategies.
• Assessment of technological limitations and future directions for pacing leads.

Main Results:

• Pacing for vasovagal syncope may benefit highly symptomatic patients with a cardioinhibitory component.
• Dual-chamber pacing is not equivalent to septal myectomy for hypertrophic obstructive cardiomyopathy but may suit specific patient groups.
• Biventricular/left ventricular pacing shows promise for heart failure, potentially combined with implantable cardioverter-defibrillator therapy.
• Dual-site atrial pacing may help prevent atrial fibrillation recurrence.

Conclusions:

• Cardiac pacing offers expanding therapeutic options for various cardiovascular diseases.
• Further lead technology development is needed for optimal coronary vein placement.
• Pacing can serve as a valuable adjunct to existing therapies for atrial fibrillation and heart failure.